Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”

Gelijkaardige items

• Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
  door: Shakshouk, Hadir, et al.
  Gepubliceerd in: (2021)
• Treatment considerations for patients with pemphigus during the COVID-19 pandemic
  door: Shakshouk, Hadir, et al.
  Gepubliceerd in: (2020)
• Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
  door: Blaszczak, Alecia, et al.
  Gepubliceerd in: (2020)
• Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
  door: Kearns, Donovan G., et al.
  Gepubliceerd in: (2021)
• Reply to “Considerations on ICU triage ethics during the COVID-19 pandemic”()
  door: Rubio, O., et al.
  Gepubliceerd in: (2021)